Statements (32)
| Predicate | Object | 
|---|---|
| gptkbp:instanceOf | gptkb:drug | 
| gptkbp:approvalYear | 1998 | 
| gptkbp:ATCCode | R03DC03 | 
| gptkbp:blackBoxWarning | serious mental health side effects | 
| gptkbp:brand | gptkb:Singulair | 
| gptkbp:chemicalFormula | C35H36ClNO3S | 
| gptkbp:contraindication | hypersensitivity to montelukast | 
| gptkbp:eliminationHalfLife | 2.7–5.5 hours | 
| gptkbp:excretion | bile | 
| gptkbp:form | gptkb:tablet chewable tablet granules | 
| gptkbp:genericAvailable | yes | 
| gptkbp:genericName | gptkb:montelukast | 
| gptkbp:legalStatus | prescription only | 
| gptkbp:manufacturer | gptkb:Merck_&_Co. | 
| gptkbp:mechanismOfAction | gptkb:leukotriene_receptor_antagonist | 
| gptkbp:metabolism | liver | 
| gptkbp:patentExpired | 2012 (US) | 
| gptkbp:pregnancyCategory | B (US) | 
| gptkbp:prescribes | adults children | 
| gptkbp:routeOfAdministration | oral | 
| gptkbp:sideEffect | abdominal pain headache cough neuropsychiatric effects | 
| gptkbp:usedFor | asthma allergic rhinitis | 
| gptkbp:bfsParent | gptkb:Merck_&_Co. | 
| gptkbp:bfsLayer | 6 | 
| https://www.w3.org/2000/01/rdf-schema#label | Singulair |